OBJECTIVE: The costs of treating eating disorders are high. Our objective was to perform a cost-utility analysis of treatment of bulimia nervosa. METHOD: 72 patients entering treatment of bulimia nervosa (ICD-10 diagnosis) completed the 15D health-related quality of life (HRQoL) questionnaire and the Eating Disorder Inventory (EDI) before and 6 months after the start of treatment. Quality-adjusted life years (QALYs) gained were calculated and cost-utility was assessed within the time horizon of 10 years. RESULTS: Baseline HRQoL was severely impaired in the patients. As a consequence of treatment, mean HRQoL improved clinically and statistically significantly. The cost per QALY gained varied from €1,455 to €16,481 (from €4,428 to €19,663 discounted at 5%) depending on the assumptions used in the analysis. DISCUSSION: HRQoL of bulimia nervosa patients is severely impaired, but treatment has a clear positive effect on HRQoL. The cost per QALY gained is comparable to many other treatments.
OBJECTIVE: The costs of treating eating disorders are high. Our objective was to perform a cost-utility analysis of treatment of bulimia nervosa. METHOD: 72 patients entering treatment of bulimia nervosa (ICD-10 diagnosis) completed the 15D health-related quality of life (HRQoL) questionnaire and the Eating Disorder Inventory (EDI) before and 6 months after the start of treatment. Quality-adjusted life years (QALYs) gained were calculated and cost-utility was assessed within the time horizon of 10 years. RESULTS: Baseline HRQoL was severely impaired in the patients. As a consequence of treatment, mean HRQoL improved clinically and statistically significantly. The cost per QALY gained varied from €1,455 to €16,481 (from €4,428 to €19,663 discounted at 5%) depending on the assumptions used in the analysis. DISCUSSION: HRQoL of bulimia nervosapatients is severely impaired, but treatment has a clear positive effect on HRQoL. The cost per QALY gained is comparable to many other treatments.
Authors: Davene R Wright; S Bryn Austin; H LeAnn Noh; Yushan Jiang; Kendrin R Sonneville Journal: Am J Public Health Date: 2014-07-17 Impact factor: 9.308
Authors: V Loimu; A A Mäkitie; L J Bäck; H Sintonen; P Räsänen; R Roine; K Saarilahti Journal: Eur Arch Otorhinolaryngol Date: 2014-07-02 Impact factor: 2.503
Authors: Veera Pohjolainen; Salla Koponen; Pirjo Räsänen; Risto P Roine; Harri Sintonen; Hasse Karlsson Journal: Qual Life Res Date: 2016-02-20 Impact factor: 4.147
Authors: Malek B Hannouf; Chander Sehgal; Jeffrey Q Cao; Joseph D Mocanu; Eric Winquist; Gregory S Zaric Journal: PLoS One Date: 2012-06-20 Impact factor: 3.240
Authors: Tamás Ágh; Gábor Kovács; Dylan Supina; Manjiri Pawaskar; Barry K Herman; Zoltán Vokó; David V Sheehan Journal: Eat Weight Disord Date: 2016-03-04 Impact factor: 4.652